Director/PDMR Shareholding

RNS Number : 4215Z

GlaxoSmithKline PLC

06 March 2013

 



Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sales of Ordinary Shares at a fair market value price of £14.75 per Ordinary Share on 5 March 2013.  These sales were to meet tax liabilities following the vesting of awards granted in 2010 under the GlaxoSmithKline Performance Share Plan (PSP) and which vested on 5 March 2013.

	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Mr R Connor	372
Mr P Thomson	319
Dr P Vallance	10,983
Ms E Walmsley	14,095
Mrs V Whyte	319

The PSP administrators have also notified the Company that, in relation to these 2010 PSP vestings, both Dr Vallance and Ms Walmsley each received one further vested share than announced on 5 March 2013.

The Company and PDMRs were advised of these transactions on 6 March 2013.      

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

6 March 2013

 

END

 

 

RDSDQLFBXXFXBBD